KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Enterprise Value (2019 - 2026)

BioNTech SE's Enterprise Value history spans 8 years, with the latest figure at -$20.1 billion for Q4 2025.

  • On a quarterly basis, Enterprise Value fell 12.25% to -$20.1 billion in Q4 2025 year-over-year; TTM through Dec 2025 was -$20.1 billion, a 12.25% decrease, with the full-year FY2025 number at -$19.5 billion, down 8.95% from a year prior.
  • Enterprise Value hit -$20.1 billion in Q4 2025 for BioNTech SE, down from -$17.0 billion in the prior quarter.
  • Over the last five years, Enterprise Value for BNTX hit a ceiling of -$1.4 billion in Q3 2021 and a floor of -$1459786.9 billion in Q1 2021.
  • Historically, Enterprise Value has averaged -$73096.8 billion across 5 years, with a median of -$16.8 billion in 2023.
  • The widest YoY moves for Enterprise Value: up 99.87% in 2022, down 563.22% in 2022.
  • Tracing BNTX's Enterprise Value over 5 years: stood at -$2.4 billion in 2021, then tumbled by 504.7% to -$14.3 billion in 2022, then dropped by 24.09% to -$17.8 billion in 2023, then fell by 0.73% to -$17.9 billion in 2024, then dropped by 12.25% to -$20.1 billion in 2025.
  • Business Quant data shows Enterprise Value for BNTX at -$20.1 billion in Q4 2025, -$17.0 billion in Q3 2025, and -$15.8 billion in Q2 2025.